MDMA
MAPS Statement on FDA Complete Response Letter on MDMA-Assisted Therapy for PTSD New Drug Application
FOR IMMEDIATE RELEASE: August 9, 2024 Aug 9, 2024 – San Jose, CA – The Multidisciplinary Association for Psychedelic Studies (MAPS) is evaluating the path forward for safe, legal access to MDMA-assisted …
Bennet, Tillis, Sinema, Paul, 15 Colleagues Call on FDA to Rely on Scientific Evidence for MDMA-Assisted Therapy to Treat Post-Traumatic Stress Disorder
Bergman Leads 60 Members in Letter to Highlight New Groundbreaking Therapy, Stop Veteran Suicide
Making Sense with Sam Harris: The Future of Psychedelic Medicine 2
MAPS, MDMA & Beyond Webinar
Join MAPS leaders Kris Lotlikar, Ismail Ali, J.D., Allison Coker, Ph.D., and Betty Aldworth to delve into the approaches and strategies MAPS is engaging during this critical juncture. After 38 years of …
Experts Endorse MDMA-assisted Therapy for PTSD
MAPS Remains Hopeful, Awaits FDA Decision on MDMA-Assisted Therapy for PTSD
Dear Friends and Allies, On June 4, 2024, the U.S. Food and Drug Administration (FDA) convened a meeting of the Psychopharmacologic Drugs Advisory Committee to evaluate Lykos Therapeutics’ (Lykos) New …
The State Committee of the Netherlands on MDMA: Report presentation by Wim van den Brink
View the report here.
Lykos Therapeutics Announces Completion of European Phase 2 Study for MDMA-Assisted Therapy for PTSD
Marijuana Moment: Feds Consider Removing MDMA From Workplace Drug Testing While Adding Fentanyl Instead
The article discusses proposed changes to federal workforce drug testing guidelines, including the removal of MDMA and MDA and the addition of fentanyl, and Betty Aldworth, director of communications and …
The New York Times: What a Terror Attack in Israel Might Reveal About Psychedelics and Trauma
This New York Times article explores the study conducted by Israeli researchers focusing on the intersection of trauma and psychedelics based on the experiences of survivors of the Tribe of Nova festival …